| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | Apr 1, 2021 | HALOZYME THERAPEUTICS, INC. | CFO | Sell | 42.5 | -4,059 | -22.45% | ✗ | $172.2K |
| Mar 2, 2021 | Mar 2, 2021 | HALOZYME THERAPEUTICS, INC. | CFO | Sell | 42.5 | -4,285 | -35.22% | ✗ | $192.9K |